Risankizumab vs. apremilast in the era of skin clearance. Veysey E. Br J Dermatol 2023 Sep 6:ljad328. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Veysey E. Risankizumab vs. apremilast in the era of skin clearance. Br J Dermatol 2023 Sep 6:ljad328. doi: 10.1093.
PMID: 37672670